Noriyuki Kinoshita

Title: Noriyuki Kinoshita: Innovator in Pharmaceutical Composition

Introduction

Noriyuki Kinoshita is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on innovative compositions that enhance drug delivery and efficacy.

Latest Patents

One of Kinoshita's latest patents is a pharmaceutical composition for oral administration. This invention comprises a modified release portion containing tamsulosin and an immediate release portion containing solifenacin. The composition ensures that the dissolution rate of each drug is comparable to current single drug formulations, achieving a maximum percentage of drug dissolution of 90% or more. This formulation offers a bioavailability equivalent to existing single drug formulations.

Another notable patent involves the isolation of FGF receptors. This patent discloses compositions and methods useful in identifying and isolating components involved in transmembrane receptor-mediated signaling. It includes novel ligands for the FGF receptor and the nucleotide sequences encoding them, which are crucial for understanding receptor-mediated signaling pathways.

Career Highlights

Kinoshita has worked with prestigious institutions such as Harvard College and Astellas Pharma GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Throughout his career, Kinoshita has collaborated with notable individuals, including Marc W. Kirschner and Takehiko Yasuji. These collaborations have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Noriyuki Kinoshita is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact drug delivery systems. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.